A Study of Efepoetin Alfa in Treating Anaemia Associated With Chronic Kidney Diseases Patient
Clinical trial NCT04155125 · COMPLETED
Trial details
- NCT number
- NCT04155125
- Sponsor
- PT Kalbe Genexine Biologics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-02
- Primary completion
- 2022-03-30
- Enrollment
- 391
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.